Neuronetics, Inc.
NASDAQ:STIM
4.41 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 74.89 | 71.348 | 65.206 | 55.312 | 49.244 | 62.656 | 52.776 | 40.433 | 34.228 |
| Cost of Revenue
| 20.729 | 19.643 | 15.483 | 11.653 | 11.554 | 15.389 | 12.447 | 9.632 | 6.622 |
| Gross Profit
| 54.161 | 51.705 | 49.723 | 43.659 | 37.69 | 47.267 | 40.329 | 30.801 | 27.606 |
| Gross Profit Ratio
| 0.723 | 0.725 | 0.763 | 0.789 | 0.765 | 0.754 | 0.764 | 0.762 | 0.807 |
| Reseach & Development Expenses
| 12.771 | 9.515 | 9.336 | 7.923 | 9.201 | 13.747 | 8.232 | 7.937 | 8.223 |
| General & Administrative Expenses
| 29.756 | 25.426 | 25.516 | 25.554 | 18.236 | 17.457 | 13.667 | 8.572 | 6.926 |
| Selling & Marketing Expenses
| 45.674 | 47.318 | 49.982 | 37.746 | 32.562 | 42.993 | 38.264 | 27.9 | 21.794 |
| SG&A
| 75.43 | 72.744 | 75.498 | 63.3 | 50.798 | 60.45 | 51.931 | 36.472 | 28.72 |
| Other Expenses
| 0 | 0 | 2.203 | 0.39 | 0.302 | 1.571 | -0.575 | 0.357 | -0.062 |
| Operating Expenses
| 88.201 | 82.259 | 84.834 | 71.223 | 59.999 | 74.197 | 60.163 | 44.409 | 36.943 |
| Operating Income
| -34.04 | -30.554 | -35.111 | -27.564 | -22.309 | -26.93 | -19.834 | -13.608 | -9.337 |
| Operating Income Ratio
| -0.455 | -0.428 | -0.538 | -0.498 | -0.453 | -0.43 | -0.376 | -0.337 | -0.273 |
| Total Other Income Expenses Net
| -9.164 | 0.365 | -2.048 | -3.629 | -5.144 | -2.114 | -4.263 | -2.451 | -1.897 |
| Income Before Tax
| -43.204 | -30.189 | -37.159 | -31.193 | -27.453 | -29.044 | -24.097 | -16.059 | -11.234 |
| Income Before Tax Ratio
| -0.577 | -0.423 | -0.57 | -0.564 | -0.557 | -0.464 | -0.457 | -0.397 | -0.328 |
| Income Tax Expense
| 0 | -0.024 | 2.048 | 4.409 | 4.824 | 5.256 | -0.575 | 3.165 | 1.773 |
| Net Income
| -43.204 | -30.189 | -39.207 | -35.602 | -32.277 | -34.3 | -24.097 | -16.059 | -11.234 |
| Net Income Ratio
| -0.577 | -0.423 | -0.601 | -0.644 | -0.655 | -0.547 | -0.457 | -0.397 | -0.328 |
| EPS
| -1.37 | -1.05 | -1.46 | -1.4 | -1.71 | -1.87 | -2.69 | -1,431.28 | -1,001.25 |
| EPS Diluted
| -1.37 | -1.05 | -1.46 | -1.4 | -1.71 | -1.87 | -2.69 | -1,431.28 | -1,001.25 |
| EBITDA
| -34.04 | -22.759 | -31.26 | -26.554 | -21.066 | -26.93 | -19.527 | -12.578 | -8.726 |
| EBITDA Ratio
| -0.455 | -0.319 | -0.479 | -0.472 | -0.428 | -0.388 | -0.37 | -0.313 | -0.255 |